All ProductsDisplaying Products by Catalog Number (6100 - 6199)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800
| Cat. No. | Product Name / Activity |
|---|---|
| 6100 | Fasentin |
| GLUT1/GLUT4 inhibitor; also Fas-sensitizer | |
| 6106 | T 3364366 |
| Potent and reversible fatty acid desaturase 1 inhibitor; orally bioavailable | |
| 6108 | Galeterone |
| CYP17 inhibitor; also androgen receptor antagonist | |
| 6110 | HJC 0416 hydrochloride |
| STAT3 inhibitor | |
| 6111 | Zoledronic Acid |
| Potent farnesyl diphosphate (FPP) synthase inhibitor | |
| 6112 | (S)-Norketamine hydrochloride |
| NMDA receptor modulator; analgesic | |
| 6113 | Liproxstatin-1 hydrochloride |
| Potent ferroptosis inhibitor | |
| 6114 | PF 06409577 |
| Potent and selective allosteric activator of AMPK | |
| 6115 | PF 06273340 |
| Potent and selective pan-Trk inhibitor; peripherally restricted | |
| 6116 | BHPI |
| ERα antagonist; also activates unfolded protein response; active in vivo | |
| 6118 | 1S,3R-RSL3 |
| Inhibits glutathione peroxidase (GPX4); induces ferroptosis | |
| 6119 | OB 24 hydrochloride |
| Potent and selective heme oxygenase 1 (HO-1) inhibitor | |
| 6122 | (RS)-2-Hydroxyglutaric acid disodium salt |
| Metabolite | |
| 6124 | (R)-2-Hydroxyglutaric acid disodium salt |
| KDM4A inhibitor; also NF-κB activator | |
| 6125 | TC JL 37 |
| Potent TYK2 inhibitor | |
| 6128 | GSK 343 |
| Potent and selective SAM-competitive EZH2 inhibitor | |
| 6130 | AP 1903 |
| Chemical inducer of protein dimerization; active in vivo | |
| 6132 | NVS PAK1 1 |
| Potent and selective PAK1 inhibitor | |
| 6133 | NVS PAK1 C |
| Negative control of NVS PAK1 1 (Cat. No. 6132) | |
| 6137 | 8-Cyclopentyl-1,3-dimethylxanthine |
| High affinity adenosine A1 receptor antagonist | |
| 6138 | SR 9243 |
| Selective LXR inverse agonist | |
| 6141 | BI-6901 |
| Potent and selective CCR10 antagonist | |
| 6143 | WZB 117 |
| GLUT inhibitor | |
| 6144 | CX08005 |
| Competitive PTP1B inhibitor | |
| 6146 | LAP |
| Photocrosslinker for hydrogels | |
| 6147 | Janelia Fluor® 549, NHS ester |
| Yellow dye (Reactive group: NHS ester). Application: flow cytometry, confocal microscopy, super resolution microscopy (SRM) including dSTORM & STED. Suitable for live cell imaging | |
| 6148 | Janelia Fluor® 646, NHS ester |
| Red dye (Reactive group: NHS ester). Application: flow cytometry, confocal microscopy, super resolution microscopy (SRM) including dSTORM & STED. Suitable for live cell imaging | |
| 6149 | PA Janelia Fluor® 549, NHS ester |
| Yellow photoactivatable dye (Reactive group: NHS ester). Application: super resolution microscopy (SRM), single molecule tracking and live cell imaging | |
| 6150 | PA Janelia Fluor® 646, NHS ester |
| Red photoactivatable dye (Reactive group: NHS ester). Application: super resolution microscopy (SRM), single molecule tracking and live cell imaging | |
| 6153 | JQEZ5 |
| Potent and selective SAM-competitive EZH2 inhibitor | |
| 6154 | MZ 1 |
| (+)-JQ1 based Degrader (PROTAC®) that preferentially degrades BRD4 | |
| 6155 | cis MZ 1 |
| Negative Control for MZ 1 (Cat. No. 6154) | |
| 6156 | VH 298 |
| High-affinity inhibitor of VHL | |
| 6157 | cis VH 298 |
| Negative control for VH 298 | |
| 6162 | TAPI 1 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6163 | AR 420626 |
| FFA3 agonist | |
| 6165 | AC 265347 |
| Biased allosteric modulator of calcium-sensing receptor (CaSR) | |
| 6166 | AMG 18 hydrochloride |
| Potent and selective IRE1α inhibitor | |
| 6167 | A 196 |
| Potent and selective SUV420H1/H2 inhibitor | |
| 6169 | PF 06726304 acetate |
| Highly potent and SAM-competitive EZH2 inhibitor | |
| 6170 | Cinacalcet hydrochloride |
| Allosteric Calcium-sensing receptor (CaSR) agonist; also CYP2D2 inhibitor and Ca2+ channel blocker; orally bioavailable | |
| 6171 | MLS 1547 |
| G protein-biased D2 partial agonist | |
| 6172 | INF 4E |
| Caspase-1 and NLRP3 inflammasome inhibitor | |
| 6174 | CVT 313 |
| Cdk2 and cdk5 inhibitor | |
| 6175 | DBHDA |
| Reagent for synthetic biology; converts cysteine to dehydroalanine | |
| 6176 | FTY 720 |
| Potent S1P receptor agonist; also immunosuppressant | |
| 6177 | AZ 13705339 |
| Highly potent PAK1 and PAK2 inhibitor | |
| 6180 | NMS 873 |
| Potent and selective p97 ATPase (VCP) allosteric inhibitor | |
| 6181 | OTX 015 |
| BET bromodomain inhibitor; orally bioavailable | |
| 6182 | Pimonidazole |
| Hypoxia detection reagent | |
| 6185 | Pemetrexed |
| Thymidylate synthetase inhibitor, also inhibits dihydrofolate reductase, GARFT and AICART | |
| 6187 | SK 216 |
| Plasminogen activator inhibitor-1 (PAI-1) inhibitor | |
| 6188 | Everolimus |
| mTOR inhibitor; Immunosuppressant | |
| 6193 | AM 4113 |
| High affinity and selective CB1 antagonist | |
| 6194 | TM 5441 |
| Plasminogen activator inhibitor-1 (PAI-1) inhibitor | |
| 6195 | SSR 149415 |
| Potent and selective vasopressin V1B antagonist | |
| 6196 | Brequinar sodium |
| Potent and selective DHODH inhibitor | |
| 6198 | GSK 6853 |
| Potent and selective BRPF1 inhibitor | |
| 6199 | BAY 876 |
| Potent and selective GLUT1 inhibitor |